Skip to main content
. 2021 Sep 12;2021(9):CD011612. doi: 10.1002/14651858.CD011612.pub3

Comparison 16. Citicoline versus Placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
16.1 Response rate 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
16.1.1 at 4 weeks 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
16.2 AE Abdominal Pain 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
16.3 AE Appetite decrease 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
16.4 AE Appetite increase 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
16.5 AE Dizziness 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
16.6 AE Diarrhoea 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
16.7 AE Headache 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
16.8 AE Insomnia 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
16.9 AE Nausea 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
16.10 AE Sedation 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
16.11 Remission rate 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
16.11.1 at 4 weeks 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected